NCI Building Systems (NYSE: NCS) is one of 47 publicly-traded companies in the “Construction & Engineering” industry, but how does it weigh in compared to its competitors? We will compare NCI Building Systems to related businesses based on the strength of its institutional ownership, analyst recommendations, profitability, dividends, earnings, valuation and risk.

Profitability

This table compares NCI Building Systems and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NCI Building Systems 3.18% 18.31% 5.31%
NCI Building Systems Competitors 3.22% 10.60% 3.47%

Earnings & Valuation

This table compares NCI Building Systems and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
NCI Building Systems $1.75 billion $156.28 million 18.04
NCI Building Systems Competitors $3.12 billion $144.36 million 18.51

NCI Building Systems’ competitors have higher revenue, but lower earnings than NCI Building Systems. NCI Building Systems is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

93.8% of NCI Building Systems shares are owned by institutional investors. Comparatively, 79.2% of shares of all “Construction & Engineering” companies are owned by institutional investors. 1.8% of NCI Building Systems shares are owned by company insiders. Comparatively, 11.1% of shares of all “Construction & Engineering” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for NCI Building Systems and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NCI Building Systems 0 1 3 0 2.75
NCI Building Systems Competitors 195 989 1554 21 2.51

NCI Building Systems currently has a consensus target price of $18.13, suggesting a potential upside of 27.19%. As a group, “Construction & Engineering” companies have a potential upside of 24.85%. Given NCI Building Systems’ stronger consensus rating and higher possible upside, equities research analysts clearly believe NCI Building Systems is more favorable than its competitors.

Volatility & Risk

NCI Building Systems has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, NCI Building Systems’ competitors have a beta of 1.27, meaning that their average share price is 27% more volatile than the S&P 500.

Summary

NCI Building Systems beats its competitors on 9 of the 13 factors compared.

About NCI Building Systems

NCI Building Systems, Inc. is a manufacturer and marketer of metal products in North America. The Company’s operating segments include Engineered building systems, Metal components and Metal coil coating. The Engineered building systems segment is engaged in the manufacturing of main frames and long bay systems, and engineering and drafting. The Metal components segment’s products include metal roof and wall panels, doors, metal partitions, metal trim, insulated metal panel (IMP) products and other related accessories. The Company manufactures and distributes a range of metal products for the non-residential construction market. It operates in the United States, Mexico, Canada and China. The Company provides metal coil coating services, and designs, engineers, manufactures and markets metal components and engineered building systems. It also provides metal coil coating services for commercial and construction applications, servicing both internal and external customers.

Receive News & Stock Ratings for NCI Building Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Building Systems Inc. and related stocks with our FREE daily email newsletter.